Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
6,571.96
6,788.09
6,955.94
6,267.37
6,224.86
7,209.27
6,127.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,571.96
6,788.09
6,955.94
6,267.37
6,224.86
7,209.27
6,127.64
Raw Material Cost
2,195.01
2,151.45
2,150.16
2,284.17
1,829.79
1,759.35
1,384.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,002.47
1,085.80
1,072.53
1,171.59
928.36
976.44
801.76
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
609.10
746.38
548.59
481.43
476.45
335.03
202.07
Selling and Distribution Expenses
2,585.80
2,974.67
2,771.41
2,632.02
2,366.53
2,824.83
2,466.01
Other Expenses
-107.10
-118.45
-62.41
-82.97
-51.72
-50.51
-42.21
Total Expenditure (Excl Depreciation)
5,321.39
5,773.83
5,918.55
5,739.54
5,083.89
5,390.54
4,432.74
Operating Profit (PBDIT) excl Other Income
1250.6
1014.3000000000001
1037.3999999999999
527.8
1141
1818.7
1694.9
Other Income
299.01
421.13
444.93
360.94
448.20
357.00
225.54
Operating Profit (PBDIT)
2,406.84
2,210.94
2,262.97
1,590.19
2,163.26
2,692.41
2,288.68
Interest
609.10
746.38
548.59
481.43
476.45
335.03
202.07
Exceptional Items
-29.73
83.72
-155.84
-498.05
-55.94
10.66
26.90
Gross Profit (PBDT)
4,376.95
4,636.63
4,805.78
3,983.20
4,395.07
5,449.92
4,742.66
Depreciation
857.27
775.54
780.66
701.41
574.09
516.68
368.25
Profit Before Tax
910.74
772.73
777.89
-90.70
1,056.78
1,851.36
1,745.26
Tax
210.57
177.93
100.55
84.64
268.46
317.30
198.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
511.63
588.53
703.32
-161.97
793.99
1,583.14
1,543.79
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
511.63
588.53
703.32
-161.97
793.99
1,583.14
1,543.79
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
187.70
7.15
-25.01
-12.52
-3.73
-47.71
3.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
699.33
595.68
678.30
-174.49
790.25
1,535.43
1,546.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
15,063.42
13,796.90
11,424.95
10,383.23
9,356.16
9,967.06
8,904.38
Earnings per share (EPS)
0.14
0.16
0.2
-0.05
0.25
0.49
0.48
Diluted Earnings per share
0.14
0.16
0.2
-0.05
0.25
0.49
0.48
Operating Profit Margin (Excl OI)
19.03%
14.94%
14.91%
8.42%
18.33%
25.23%
27.66%
Gross Profit Margin
26.9%
22.81%
22.41%
9.74%
26.2%
32.85%
34.49%
PAT Margin
7.79%
8.67%
10.11%
-2.58%
12.76%
21.96%
25.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -3.18% vs -2.41% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 17.39% vs -12.18% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 17.77% vs -1.55% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -18.39% vs 36.06% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Luye Pharma Group Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
6,571.96
6,463.01
108.95
1.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,571.96
6,463.01
108.95
1.69%
Raw Material Cost
2,195.01
2,973.83
-778.82
-26.19%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,002.47
717.03
285.44
39.81%
Power Cost
0
0
0.00
Manufacturing Expenses
609.10
125.41
483.69
385.69%
Selling and Distribution Expenses
2,585.80
1,744.89
840.91
48.19%
Other Expenses
-107.10
-58.83
-48.27
-82.05%
Total Expenditure (Excl Depreciation)
5,321.39
4,972.87
348.52
7.01%
Operating Profit (PBDIT) excl Other Income
1,250.57
1,490.14
-239.57
-16.08%
Other Income
299.01
188.23
110.78
58.85%
Operating Profit (PBDIT)
2,406.84
2,097.69
309.15
14.74%
Interest
609.10
125.41
483.69
385.69%
Exceptional Items
-29.73
0.00
-29.73
Gross Profit (PBDT)
4,376.95
3,489.18
887.77
25.44%
Depreciation
857.27
419.32
437.95
104.44%
Profit Before Tax
910.74
1,552.96
-642.22
-41.35%
Tax
210.57
254.28
-43.71
-17.19%
Provisions and contingencies
0
0
0.00
Profit After Tax
511.63
1,318.62
-806.99
-61.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
511.63
1,318.62
-806.99
-61.20%
Share in Profit of Associates
0
0
0.00
Minority Interest
187.70
10.67
177.03
1,659.14%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
699.33
1,329.29
-629.96
-47.39%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
15,063.42
6,932.53
8,130.89
117.29%
Earnings per share (EPS)
0.14
0.44
-0.30
-68.18%
Diluted Earnings per share
0.14
0.44
-0.30
-68.18%
Operating Profit Margin (Excl OI)
19.03%
23.06%
0.00
-4.03%
Gross Profit Margin
26.90%
30.52%
0.00
-3.62%
PAT Margin
7.79%
20.40%
0.00
-12.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 657.20 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -3.18% vs -2.41% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 69.93 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 17.39% vs -12.18% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.78 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 17.77% vs -1.55% in Dec 2023
Annual - Interest
Interest 60.91 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -18.39% vs 36.06% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.03%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






